Verona Pharma Plc PEG Ratio

Verona Pharma Plc's peg ratio stands at 1844.95. That is above the Healthcare sector average of 2.56. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Verona Pharma Plc sits higher the Healthcare benchmark (2.56) with a PEG ratio of 1844.95. That is roughly 71976.5% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether 1844.95 is attractive depends on Verona Pharma Plc's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how Verona Pharma Plc's PEG ratio evolved across reporting periods, while the comparison chart places VRNA next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, PEG ratio is commonly used to spot outliers. Verona Pharma Plc's reading of 1844.95 (sector avg 2.56) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.